Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices

被引:103
|
作者
Jutabha, R
Jensen, DM
Martin, P
Savides, T
Han, SH
Gornbein, J
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Hlth Sci Ctr, Dept Med,Div Digest Dis, Los Angeles, CA USA
[2] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[3] Univ Calif San Diego, Med Ctr, Ctr Ulcer Res & Educ, Digest Dis Res Ctr, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Med Ctr, Cedars Sinai Med Ctr, San Diego, CA 92103 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA
关键词
D O I
10.1053/j.gastro.2005.01.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Standard care for prevention of first esophageal variceal hemorrhage is beta-blockade, but this may be ineffective or unsafe. Our purpose was to compare endoscopic banding with propranolol for prevention of first variceal hemorrhage. Methods: In a multicenter, prospective trial, 62 patients with cirrhosis with high-risk esophageal varices were randomized to propranolol (titrated to reducing resting pulse by 25%) or banding (performed monthly until varices were eradicated) and were followed up on the same schedule for a mean duration of 15 months. The primary end point was treatment failure, defined as the development of endoscopically documented variceal hemorrhage or a severe medical complication requiring discontinuation of therapy. Direct costs were estimated from Medicare reimbursements and fixed or variable charges for services up to treatment failure. Results: Background variables of the treatment groups were similar. The trial was stopped early after an interim analysis showed that the failure rate of propranolol was significantly higher than that of banding (6/31 vs. 0/31; difference, 1.9.4%; P =.0098; 95% confidence interval for true difference, 6.4%-37.2%). Significantly more propranolol than banding patients had esophageal variceal hemorrhage (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%), and the cumulative mortality rate was significantly higher in the propranolol than in the banding group (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%). Direct costs of care were not significantly different. Conclusions: For patients with cirrhosis with high-risk esophageal varices and no history of variceal hemorrhage, propranolol-treated patients had significantly higher failure rates of failure, first esophageal varix hemorrhage, and cumulative mortality than banding patients. Direct costs of medical care were not significantly different.
引用
收藏
页码:870 / 881
页数:12
相关论文
共 50 条
  • [41] A RANDOMIZED DOUBLE-BLIND INTERVENTION STUDY ON THE EFFECT OF CALCIUM SUPPLEMENTATION ON ESOPHAGEAL PRECANCEROUS LESIONS IN A HIGH-RISK POPULATION IN CHINA
    WANG, LD
    QIU, SL
    YANG, GR
    LIPKIN, M
    NEWMARK, HL
    YANG, CS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1993, 2 (01) : 71 - 78
  • [42] Randomized study comparing chemotherapy ±GM-CSF in high-risk MDS and AML following MDS (MDS-AML).
    Ohm, AC
    Hast, R
    Bernell, P
    Celsing, F
    Dahl, IM
    Dybedal, I
    Lindberg, G
    Linder, O
    Löfvenberg, E
    Nilsson-Ehle, H
    Samuelsson, J
    Tangen, J
    Turesson, I
    Wallvik, J
    Winquist, I
    Öberg, G
    Björkholm, M
    Hellström-Lindberg, E
    BLOOD, 2000, 96 (11) : 148A - 148A
  • [43] Validation of Spleen Stiffness Measurement for Screening of High-risk Esophageal Varices Among Cirrhotic Patients in Indonesia: A Single-Center Cross-sectional Study
    Nababan, Saut Horas H.
    Aprilicia, Gita
    Akbar, Pitt
    Kalista, Kemal Fariz
    Jasirwan, Chyntia Olivia Maurine
    Kurniawan, Juferdy
    Lesmana, Cosmas Rinaldi A.
    Sulaiman, Andri S.
    Hasan, Irsan
    Gani, Rino A.
    ACTA MEDICA INDONESIANA, 2024, 56 (03) : 276 - 281
  • [44] Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study
    Bellver, J
    Muñoz, EA
    Ballesteros, A
    Soares, SR
    Bosch, E
    Simón, C
    Pellicer, A
    Remohí, J
    HUMAN REPRODUCTION, 2003, 18 (11) : 2283 - 2288
  • [45] Effects of Diet and Exercise Interventions to Prevent Gestational Diabetes Mellitus in Pregnant Women With High-Risk Factors in China: A Randomized Controlled Study
    Deng, Yafang
    Hou, Yixuan
    Wu, Liping
    Liu, Yanping
    Ma, Liangkun
    Yao, Aimin
    CLINICAL NURSING RESEARCH, 2022, 31 (05) : 836 - 847
  • [46] SINGLE-DOSE ANTIBIOTIC-PROPHYLAXIS IN PATIENTS AT HIGH-RISK FOR INFECTION IN BILIARY SURGERY - A PROSPECTIVE AND RANDOMIZED STUDY COMPARING CEFONICID WITH MEZLOCILLIN
    TARGARONA, EM
    GARAU, J
    MUNOZRAMOS, C
    ROSET, F
    LITE, J
    MATAS, E
    MARCO, C
    SURGERY, 1990, 107 (03) : 327 - 334
  • [47] Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
    Friederike Schaub
    Robert Hoerster
    Petra Schiller
    Moritz Felsch
    Daria Kraus
    Marouan Zarrouk
    Bernd Kirchhof
    Sascha Fauser
    Trials, 19
  • [48] Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
    Schaub, Friederike
    Hoerster, Robert
    Schiller, Petra
    Felsch, Moritz
    Kraus, Daria
    Zarrouk, Marouan
    Kirchhof, Bernd
    Fauser, Sascha
    TRIALS, 2018, 19
  • [49] THE EFFICACY OF VONOPRAZAN COMPARING WITH HIGH DOSE PROTON PUMP INHIBITOR IN RECURRENCE BLEEDING RATE OF HIGH-RISK PEPTIC ULCER PATIENTS: A RANDOMIZED CONTROLLED STUDY (A PRELIMINARY ANALYSIS)
    Wong, Thanawin
    Pattarapuntakul, Tanawat
    Sripongpun, Pimsiri
    Chamroonkul, Naichaya
    Netinatsunton, Nisa
    Jandee, Sawangpong
    Kaewdech, Apichat
    GASTROENTEROLOGY, 2023, 164 (06) : S842 - S842
  • [50] Eradication of H-pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users:: A prospective randomized study.
    Chan, FKL
    Sung, JY
    Suen, R
    Lee, YT
    Leung, WK
    Leung, VKS
    Wu, JCY
    Chung, CS
    GASTROENTEROLOGY, 1998, 114 (04) : A87 - A87